← FDATracker
HomeAdverse Events

OXYCONTIN (NDA 22-272) Adverse Event: Osteopenia

OXYCONTIN (NDA 22-272) Adverse Event: Osteopenia is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: OXYCONTIN (NDA 22-272); Product category: Drug; Primary reaction: Osteopenia.

Primary drugOXYCONTIN (NDA 22-272)
Product categoryDrug
Primary reactionOsteopenia
All reactionsOsteopenia; Osteoporosis
SeriousnessSerious
Patient outcomeUnknown
Patient sexFemale
All drugs reportedOXYCONTIN (NDA 22-272); FORTEO; FORTEO; CALCIUM
Reporter countryUS
Reporter type5
Report date20140312
Report ID10004519

🔍 Search all adverse events →